Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Eshelman Fredric N
Relationship:   10% Owner
City:   Wilmington
State:   NC
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   8,151,654    

Indirect Shares

  3,933,809      
Direct Value   $86,486,376    

Indirect Value

  $13,868,647      
Total Shares   12,085,463      
Total Value   $100,355,023      


Bausch Health Companies Inc
 $240,894 G1 Therapeutics Inc
 $827,500 Eyenovia Inc
 $920,464 Liquidia Technologies Inc
 $84,497,517 Bausch Health Companies Inc
 $240,894 G1 Therapeutics Inc
 $827,500 Eyenovia Inc
 $920,464 Liquidia Technologies Inc
 $84,497,517
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    7   
    3    

     Stock price went up :

    0   
    0    
     Stock price went down :
    7   
    3    
   
     Gain/Loss Ratio :
   -7.0   
   -3.0   
     Percentage Gain/Loss :
   -45.7%
 -43.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmaceutical Product Developme... PPDI Executive Chairman, Di... 2011-12-05 0 2011-12-05 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director, 10% Owner 2014-07-02 0 2014-07-02 0    Premium*  
            Bausch Health Companies Inc BHC Director 2017-05-05 38,298 2016-03-11 0    Premium*  
            G1 Therapeutics Inc GTHX Director, 10% Owner 2017-11-13 250,000 2017-11-13 3,439,151    Premium*  
            Eyenovia Inc EYEN Director 2020-09-11 1,292,787 2020-09-11 319,085    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2020-11-25 6,570,569 2020-11-25 175,573    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-11-10 4 B $16.48 $212,411 D/D 12,889 1,624,109 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-11-18 4 B $15.87 $374,929 D/D 23,625 1,647,734 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-11-21 4 B $15.48 $193,005 D/D 12,468 1,660,202 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-11-23 4 B $16.22 $247,809 D/D 15,278 1,675,480 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-11-25 4 B $16.00 $108,832 D/D 6,802 1,682,282 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-01 4 B $17.60 $440,458 D/D 25,026 1,707,308 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-02 4 B $17.50 $483,910 D/D 27,652 1,734,960 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-05 4 B $17.65 $1,953,220 D/D 110,664 1,845,624 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-13 4 B $17.00 $1,608,387 D/D 94,611 1,940,235 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-14 4 B $16.70 $334,935 D/D 20,056 1,960,291 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-15 4 B $16.88 $293,020 D/D 17,359 1,977,650 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-05 4 B $20.55 $313,120 D/D 15,237 1,992,887 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-06 4 B $20.87 $317,996 D/D 15,237 2,008,124 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-08 4 B $22.52 $335,863 D/D 14,914 2,023,038 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-09 4 B $22.59 $344,204 D/D 15,237 2,038,275 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-12 4 B $22.69 $507,144 D/D 22,351 2,060,626 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-13 4 B $23.45 $529,829 D/D 22,594 2,158,220 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-14 4 B $23.75 $539,434 D/D 22,713 2,180,933 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-15 4 B $23.91 $169,809 D/D 7,102 2,188,035 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-21 4 B $16.15 $38,760 D/D 2,400 2,215,435 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-22 4 B $16.93 $592,550 D/D 35,000 2,250,435 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-23 4 B $17.73 $354,600 D/D 20,000 2,270,435 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-24 4 B $17.99 $485,730 D/D 27,000 2,297,435 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-25 4 B $18.45 $26,826 D/D 1,454 2,298,889 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-31 4 B $20.06 $1,405,705 D/D 70,075 2,537,716 3.92 -

  148  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed